Results 41 to 50 of about 10,826 (205)

Drug‐Induced Liver Injury by Selective Androgenic Receptor Modulators

Hepatology Communications, 2020
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.
Joan Ericka Flores, Shivakumar Chitturi, Sarah Walker   +2 more
doaj   +1 more source

Hepatotoxicity of anabolic androgenic steroids in sport

Journal of Education, Health and Sport, 2020
Introduction and purpose: Anabolic-androgenic steroids (AAS) abuse is a common practice among professional as well as recreational athletes. The prevalence of this phenomenon seems to be continuously escalating, too.
Michał Jakub Sekuła, Blanka Świerczyńska, Krzysztof Smoluchowski, Adrian Undziakiewicz, Halina Piecewicz-Szczęsna   +4 more
doaj   +1 more source

Effects of Abuse of Anabolic Androgenic Steroids on Iraqi Athletes

Iraqi Journal of Pharmaceutical Sciences, 2017
Anabolic androgenic steroids (AAS) are man-made derivatives of the male sex hormone testosterone, originally designed for therapeutic uses to provide higher anabolic potency with lower androgenic effects.
Al-Muhannad M. Taher, May S. Al-Sabbagh, Dawser K. Al-Khashali   +2 more
doaj   +3 more sources

Knowledge, attitudes and use of anabolic-androgenic steroids among male gym users: A community based survey in Riyadh, Saudi Arabia

Saudi Pharmaceutical Journal, 2019
Recreational use of anabolic-androgenic steroids (AAS) is a growing worldwide public health concern. However, studies assessing the level of awareness and knowledge of its effects on health are fairly limited, especially in developing countries ...
Fares F Alharbi, Islam Gamaleddin, Samar F Alharbi, Omar Almodayfer, Fahad Allohidan, Mohammed Alghobain, Asaad Arafah, Khaled Al-Surimi   +7 more
doaj   +1 more source

A qualitative exploration of the motivations underlying anabolic-androgenic steroid use from adolescence into adulthood [PDF]

, 2016
Background: This study explored the direct experience of anabolic androgenic steroid (AAS) use by young men, with an emphasis on how motivations progressed from adolescent initiation to more entrenched usage.
Alwyn, Tina, Dunn, Michael, Harris, Marc Ashley   +2 more
core   +2 more sources

Anabolic-androgenic steroids and cardiovascular risk

Chinese Medical Journal, 2019
. Objective:. Anabolic-androgenic steroids (AAS) represents a group of synthetic testosterone derivatives that play an important role in clinical treatment.
Jian-Di Liu, Yan-Qing Wu, Yi Cui
doaj   +1 more source

The impact of anabolic androgenic steroids abuse and type of training on left ventricular remodeling and function in competitive athletes [PDF]

, 2014
Background/Aim. Long-term intensive training is associated with distinctive cardiac adaptations which are known as athlete’s heart. The aim of this study was to determine whether the use of anabolic androgenic steroids (AAS) could affect ...
Babić Rade, Ilić Ivan, Nešković Aleksandar N., Putniković Biljana, Stanković Ivan, Vlahović-Stipac Alja, Đorđević Vitomir   +6 more
core   +1 more source

Resting spontaneous baroreflex sensitivity and cardiac autonomic control in anabolic androgenic steroid users

Clinics, 2018
OBJECTIVES: Misuse of anabolic androgenic steroids in athletes is a strategy used to enhance strength and skeletal muscle hypertrophy. However, its abuse leads to an imbalance in muscle sympathetic nerve activity, increased vascular resistance, and ...
Marcelo R. dos Santos, Ana L.C. Sayegh, Rafael Armani, Valéria Costa-Hong, Francis R. de Souza, Edgar Toschi-Dias, Luiz A. Bortolotto, Mauricio Yonamine, Carlos E. Negrão, Maria-Janieire N.N. Alves   +9 more
doaj   +1 more source

Polypharmacy among anabolic-androgenic steroid users: A descriptive metasynthesis [PDF]

, 2015
Background: As far as we are aware, no previous systematic review and synthesis of the qualitative/descriptive literature on polypharmacy in anabolic-androgenic steroid(s) (AAS) users has been published. Method: We systematically reviewed and synthesized
AJ Gruber, AJ Gruber, AJ Gruber, AJ McBride, AJ Viera, Astrid Bjørnebekk, B Hegazy, B Larance, C Ahlgrim, C Wilson-Fearon, Cecilie Schou Andreassen, CN Schäfer, CS Cornford, D Hoff, D Moher, D Moher, D Sagoe, D Sagoe, DA Malone Jr, DL Katz, Dominic Sagoe, E Chahla, E Pappa, F Klötz, G Kanayama, G Kanayama, G Kanayama, G McKillop, GS Goldfield, H Angoorani, H Geyer, HB Moss, HB Moss, HG Pope Jr, HG Pope Jr, IBM Corp, J Bilard, JA Smith, JD Wines, Jim McVeigh, JR Hoffman, K Skårberg, K Skårberg, K Skårberg, KA Clauson, L Degenhardt, L Lundholm, LJ Silvester, M Chandler, M Dunn, M Evans-Brown, Marie-Stella Essilfie, MJ Evans-Brown, N Gårevik, P Korkia, P Korkia, P Lenehan, PJ Fudala, PJ Perry, PJ Perry, R Davies, R Peters, R Shaw, RH Strauss, RP Kusserow, RT Dawson, S Darke, SM Filiault, Ståle Pallesen, T Dodge, T Hildebrandt, TA Pagonis, V Tallon, VD Hope, W Rashid   +74 more
core   +2 more sources

Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study

Swiss Medical Weekly
BACKGROUND: The non-medical use of anabolic androgenic steroids for the improvement of aesthetic and sports performance purposes has become a global substance use disorder, particularly among men in recreational sports.
Raphael Magnolini, Kuvinda Kossinna, Daniel Bjasch, Muriel Kruijver, Philip Bruggmann, Oliver Senn   +5 more
doaj   +1 more source